Kinome expression profiling and prognosis of basal breast cancers. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Molecular Cancer Year : 2011

Kinome expression profiling and prognosis of basal breast cancers.


UNLABELLED: ABSTRACT: BACKGROUND: Basal breast cancers (BCs) represent ~15% of BCs. Although overall poor, prognosis is heterogeneous. Identification of good- versus poor-prognosis patients is difficult or impossible using the standard histoclinical features and the recently defined prognostic gene expression signatures (GES). Kinases are often activated or overexpressed in cancers, and constitute targets for successful therapies. We sought to define a prognostic model of basal BCs based on kinome expression profiling. METHODS: DNA microarray-based gene expression and histoclinical data of 2515 early BCs from thirteen datasets were collected. We searched for a kinome-based GES associated with disease-free survival (DFS) in basal BCs of the learning set using a metagene-based approach. The signature was then tested in basal tumors of the independent validation set. RESULTS: A total of 591 samples were basal. We identified a 28-kinase metagene associated with DFS in the learning set (N = 73). This metagene was associated with immune response and particularly cytotoxic T-cell response. On multivariate analysis, a metagene-based predictor outperformed the classical prognostic factors, both in the learning and the validation (N = 518) sets, independently of the lymphocyte infiltrate. In the validation set, patients whose tumors overexpressed the metagene had a 78% 5-year DFS versus 54% for other patients (p = 1.62E-4, log-rank test). CONCLUSIONS: Based on kinome expression, we identified a predictor that separated basal BCs into two subgroups of different prognosis. Tumors associated with higher activation of cytotoxic tumor-infiltrative lymphocytes harbored a better prognosis. Such classification should help tailor the treatment and develop new therapies based on immune response manipulation.
Fichier principal
Vignette du fichier
1476-4598-10-86.pdf (553.03 Ko) Télécharger le fichier
1476-4598-10-86-S1.XLS (23.5 Ko) Télécharger le fichier
1476-4598-10-86-S10.XLS (189 Ko) Télécharger le fichier
1476-4598-10-86-S11.PPT (204 Ko) Télécharger le fichier
1476-4598-10-86-S2.DOC (53 Ko) Télécharger le fichier
1476-4598-10-86-S3.XLS (290 Ko) Télécharger le fichier
1476-4598-10-86-S4.XLS (22.5 Ko) Télécharger le fichier
1476-4598-10-86-S5.XLS (29 Ko) Télécharger le fichier
1476-4598-10-86-S6.XLS (17.5 Ko) Télécharger le fichier
1476-4598-10-86-S7.XLS (21.5 Ko) Télécharger le fichier
1476-4598-10-86-S8.XLS (28 Ko) Télécharger le fichier
1476-4598-10-86-S9.PPT (1009 Ko) Télécharger le fichier
1476-4598-10-86.xml (116.53 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other
Format Other

Dates and versions

inserm-00614833 , version 1 (16-08-2011)



Renaud Sabatier, Pascal Finetti, Emilie Mamessier, Stéphane Raynaud, Nathalie Cervera, et al.. Kinome expression profiling and prognosis of basal breast cancers.. Molecular Cancer, 2011, 10 (1), pp.86. ⟨10.1186/1476-4598-10-86⟩. ⟨inserm-00614833⟩
109 View
186 Download



Gmail Mastodon Facebook X LinkedIn More